Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-16

Clinical Trial Update: Effects of Linagliptin on Endothelial Function [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of linagliptin on endothelial function in patients with type 2 diabetes and coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linagliptin (linagliptin)

Snippet

Sponsor: Medical University of Graz | Conditions: Type 2 Diabetes, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-12-16